Taiho Oncology RX
FDA Approved Drugs
Taiho Oncology RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 4
- Latest Approval Date Sep 30, 2022
- Data Source FDA
- First Approval Date Sep 22, 2015
Company Overview
Social Profiles
Company Snapshot
Taiho Oncology RX
101 Carnegie Center, Suite 101 Princeton, New Jersey 08540
U.S.A
www.taihooncology.com/us/ View on MapFDA Approved Drug Records ( 4 records )
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
5 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
4 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
INQOVI
Application Number
212576
Product Number
1
Active Ingredient
CEDAZURIDINE; DECITABINE
Dosage Form
-
Strength
100MG;35MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.